http://www.acc.org/Feed?clinicalTopicID=8e0665e1-fe1f-4915-88f0-f894baeef01f Clinical Topic Feed: Pulmonary Hypertension en /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/27/19/07/Heart-Failure-Trials-Featured-at-ACC26 ACC.26 featured several late-breaking heart failure clinical trials, including two focused on subgroups of heart failure that until now had limited data to guide therapies. 1777460220000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/07/14/54/accel-lite-07apr2026 Pulmonary arterial hypertension (PAH) remains a devastating, progressive disease with high morbidity and mortality despite advances in targeted therapies. 1775573940000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026 Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-1045am-cadence-acc-2026 Sotatercept, an activin signaling inhibitor, was associated with significant improvements in blood pressure and vascular health in patients with heart failure with preserved ejection fraction (HFpEF) and severe combined post and precapillary pulmonary hypertension (CpcPH), according to results of the CADENCE study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation. 1774800360000 Articles and Stories /Latest-in-Cardiology/Articles/2026/01/28/14/24/eagles-eye-view-28jan2025 In this week’s View, Dr. Eagle looks at exercise systolic blood pressure (SBP) during stress testing related to cardiovascular (CV) events. 1769610360000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/01/20/18/24/Molecular-Imaging-Biomarker Uptake of fluorine-18-fibroblast activation protein inhibitor (18F-FAPI) in the right ventricular (RV) free wall, as captured by PET/CT, is a promising, noninvasive indicator for pulmonary arterial hypertension (PAH), according to new research published Jan. 8 in JACC: Cardiovascular Imaging. 1768998600000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/18/16/40/New-ACC-AHA-Guideline-Addresses-Management-of-Congenital-Heart-Disease-in-Adults The ACC and AHA, in collaboration with several leading medical societies, have released a new clinical guideline focused on the management of adults with congenital heart disease (ACHD). The guideline provides updated recommendations for monitoring, counseling and treating ACHD and replaces previous guidance released in 2018. 1766084940000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/01/01/Editors-Corner-Pulmonary-Hypertension Our cover story this month takes on the daunting task of describing the complexities of pulmonary hypertension (PH). The story emphasizes that patients with PH need early recognition and treatment. 1761999600000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/01/01/Cover-Story-Pulmonary-Hypertension Despite affecting approximately 1% of the population and carrying significant mortality risk, pulmonary hypertension (PH) remains underrecognized compared to other cardiovascular conditions. Several interconnected factors contribute to this clinical blind spot. 1761999540000 Articles and Stories